0
Department of Health and Human Services Awarded a Contract to VIR BIOTECHNOLOGY, INC. for $65,867,803.99
Signed on
9/28/2022, 12:00 AM
VIR BIOTECHNOLOGY, INC. Government Contract #75A50122C00081
VIR BIOTECHNOLOGY, INC. was awarded a contract with the United States Government for $65,867,803.99. The contract was awarded by the agency office BARDA - ASPR / DAAPPO / BARDA DCMA, which is a division with the Office of Assistant Secretary for Preparedness and Response within the Department of Health and Human Services.
Summary of Award
The recipient of the federal contract is VIR BIOTECHNOLOGY, INC., a U.S.-Owned Business based in San Francisco, California. The contract, funded by the Department of Health and Human Services, is for pre-exposure prophylactic monoclonal antibodies to prevent influenza illness and medical countermeasures for emerging pathogens, totaling $65,867,803.99. Notable spending includes $62,943,270.64 towards health R&D services and $2,924,533.35 for basic research.